SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-035369
Filing Date
2020-12-28
Accepted
2020-12-28 20:44:13
Documents
2
Period of Report
2020-12-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 EX-24 DOCUMENT attachment1.htm EX-24 4651
  Complete submission text file 0000899243-20-035369.txt   7665
Mailing Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054
Business Address 4500 GREAT AMERICAN PARKWAY SUITE 100 #29 SANTA CLARA CA 95054 650-800-6676
Vincera Pharma, Inc. (Issuer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4500 GREAT AMERICA PKWY STE. 100 #29 SANTA CLARA CA 95054
Business Address
Bushnell Laura I. (Reporting) CIK: 0001832575 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39244 | Film No.: 201420017